454 WATSON
Pill imprint 454 WATSON has been identified as Gemfibrozil 600 mg.
Gemfibrozil is used in the treatment of high cholesterol; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iv, elevated vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy.
Gemfibrozil 600 mg is not subject to the Controlled Substances Act.
See also related documents.
Gemfibrozil Images
- Imprint:
-
454
WATSON - Strength:
- 600 mg
- Color:
- Orange
- Size:
- 19.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- calcium stearate
silicon dioxide colloidal
croscarmellose sodium
FD&C Red No. 40 Aluminium Lake
FD&C Yellow No. 6 Aluminum Lake
hydroxypropyl cellulose
microcrystalline cellulose
polyethylene glycol
polysorbate 80
pregelatinized starch
titanium dioxide
- Drug Class:
- Fibric acid derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- 00591-0454
Advertisement
More Gemfibrozil resources
- Gemfibrozil
- Gemfibrozil (Wolters Kluwer)
- gemfibrozil (Cerner Multum)
- gemfibrozil (Micromedex) - Includes Dosage Information
- Gemfibrozil (AHFS DI)
- Gemfibrozil (FDA)
- Gemfibrozil (Wolters Kluwer)
Search Again
